Forefront Analytics’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$438K Buy
18,210
+5,120
+39% +$134K 0.48% 22
2026
Q1
$368K Sell
13,090
-6,014
-31% -$160K 0.33% 24
2025
Q4
$476K Buy
19,104
+6,526
+52% +$165K 0.42% 23
2025
Q3
$320K Sell
12,578
-850
-6% -$21K 0.31% 29
2025
Q2
$325K Buy
13,428
+4,777
+55% +$111K 0.36% 29
2025
Q1
$219K Sell
8,651
-6,252
-42% -$164K 0.25% 31
2024
Q4
$395K Buy
14,903
+609
+4% +$16.5K 0.18% 43
2024
Q3
$414K Sell
14,294
-755
-5% -$22K 0.2% 48
2024
Q2
$421K Buy
15,049
+2,189
+17% +$60.3K 0.2% 48
2024
Q1
$357K Buy
12,860
+2,531
+25% +$70.2K 0.17% 51
2023
Q4
$297K Buy
10,329
+2,712
+36% +$82K 0.15% 50
2023
Q3
$253K Sell
7,617
-118
-2% -$4.17K 0.14% 50
2023
Q2
$284K Buy
7,735
+1,661
+27% +$64.7K 0.16% 49
2023
Q1
$248K Sell
6,074
-313
-5% -$13.5K 0.13% 61
2022
Q4
$327K Sell
6,387
-1,187
-16% -$56.9K 0.17% 51
2022
Q3
$329K Buy
7,574
+880
+13% +$42.8K 0.18% 42
2022
Q2
$348K Buy
6,694
+299
+5% +$15.2K 0.17% 42
2022
Q1
$336K Buy
6,395
+1,713
+37% +$88.9K 0.12% 43
2021
Q4
$274K Buy
+4,682
New +$232K 0.09% 46

Other funds holding PFE

Forefront Analytics's PFE Position: Q2 2026 in Review

Forefront Analytics increased its Pfizer (PFE) stake by 39% in Q2 2026, buying an estimated $134K and bringing the position to 18,210 shares worth $438K. The position accounts for 0.48% of the portfolio, ranked #22.

Forefront Analytics first reported a position in PFE in Q4 2021 and has held it in 19 quarters since. The position peaked at $476K in Q4 2025. 2,822 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Forefront Analytics held 18,210 shares of Pfizer worth $438K as of Q2 2026.
  • Forefront Analytics bought 5,120 Pfizer shares in Q2 2026, an estimated $134K.
  • Pfizer made up 0.48% of Forefront Analytics's portfolio in Q2 2026, its #22 holding.
  • Forefront Analytics first reported a position in Pfizer in Q4 2021 and has held it in 19 quarters since.
  • Forefront Analytics's Pfizer position peaked at $476K in Q4 2025.
  • 2,822 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Forefront Analytics's 13F filing for Q2 2026, filed 13 Aug 2026.